Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Forecast & Target Price

View the latest analyst price targets and forecasts to stay informed on market expectations. Click here to open.

Dollar change -0.38
Percentage change -1.25	%

Peers: DXCM PODD MDT ABT SYK BSX EW LMT AMGN BIIB

| Held by: IJR VTI IWM VB VXF VBK SPSM IWO IHI IJS

Index	RUT	P/E	-	EPS (ttm)	-1.94	Insider Own	0.81%	Shs Outstand	65.55M	Perf Week	7.79%
Market Cap	1.97B	Forward P/E	-	EPS next Y	-1.21	Insider Trans	-7.70%	Shs Float	65.14M	Perf Month	-8.27%
Income	-126.78M	PEG	-	EPS next Q	-0.21	Inst Own	112.73%	Short Float	12.88%	Perf Quarter	-32.31%
Sales	854.35M	P/S	2.31	EPS this Y	50.64%	Inst Trans	-0.87%	Short Ratio	6.27	Perf Half Y	-41.95%
Book/sh	3.62	P/B	8.30	EPS next Y	28.41%	ROA	-13.36%	Short Interest	8.39M	Perf Year	54.29%
Cash/sh	7.21	P/C	4.17	EPS next 5Y	16.00%	ROE	-45.96%	52W Range	18.45 - 53.69	Perf YTD	1.56%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-6.11%	ROI	-19.36%	52W High	-44.05%	Beta	1.33
Dividend TTM	-	Quick Ratio	2.32	Sales past 5Y	36.59%	Gross Margin	49.79%	52W Low	62.82%	ATR (14)	1.80
Dividend Ex-Date	-	Current Ratio	2.90	EPS Y/Y TTM	39.76%	Oper. Margin	-15.64%	RSI (14)	42.08	Volatility	5.62% 5.86%
Employees	2400	Debt/Eq	2.00	Sales Y/Y TTM	10.75%	Profit Margin	-14.84%	Recom	1.78	Target Price	53.30
Option/Short	Yes / Yes	LT Debt/Eq	1.76	EPS Q/Q	29.91%	Payout	-	Rel Volume	0.98	Prev Close	30.42
Sales Surprise	8.39%	EPS Surprise	14.07%	Sales Q/Q	31.43%	Earnings	Nov 06 AMC	Avg Volume	1.34M	Price	30.04
SMA20	-2.57%	SMA50	-15.73%	SMA200	-21.41%	Trades		Volume	1,311,470	Change	-1.25%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-06-24	Initiated	Bernstein	Outperform	$42
Oct-04-24	Initiated	Goldman	Neutral	$46
Oct-02-24	Initiated	RBC Capital Mkts	Outperform	$65
Aug-22-24	Initiated	Morgan Stanley	Equal-Weight	$45
Aug-08-24	Initiated	Canaccord Genuity	Buy	$57
May-30-24	Initiated	Redburn Atlantic	Buy	$60
May-22-24	Upgrade	Citigroup	Neutral → Buy	$40 → $57
Apr-29-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$21 → $45
Apr-25-24	Upgrade	Leerink Partners	Market Perform → Outperform	$34 → $45
Mar-26-24	Upgrade	Stifel	Hold → Buy	$24 → $37
Aug-04-23	Downgrade	Citigroup	Buy → Neutral	$45 → $33
May-05-23	Downgrade	BofA Securities	Neutral → Underperform	$45 → $33
Apr-24-23	Downgrade	Raymond James	Outperform → Mkt Perform
Mar-29-23	Initiated	UBS	Neutral	$45
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-15-22	Upgrade	Wells Fargo	Underweight → Equal Weight	$43
Oct-18-22	Initiated	Barclays	Overweight	$75
Oct-12-22	Initiated	Jefferies	Buy	$75
Aug-09-22	Downgrade	Wells Fargo	Overweight → Underweight	$82 → $49
Mar-02-22	Resumed	BofA Securities	Neutral	$130

Show Previous Ratings

Today 06:59AM	Tandem Diabetes Care, Inc. (TNDM): An Oversold Healthcare Stock to Invest In Now (Insider Monkey)
Nov-21-24 04:05PM	Tandem Diabetes Care Announces Upcoming Conference Presentations (Business Wire)
Nov-08-24 06:56AM	Tandem Diabetes price target lowered to $37 from $39 at Baird (TipRanks) -8.16%
Nov-07-24 06:25PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research)
07:57AM	Q3 2024 Tandem Diabetes Care Inc Earnings Call (Thomson Reuters StreetEvents)
02:21AM	Loading…
02:21AM	Tandem Diabetes Care Inc (TNDM) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... (GuruFocus.com)
Nov-06-24 06:30PM	Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:25PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance (Business Wire)
Oct-30-24 04:05PM	Tandem Diabetes Care Announces Upcoming Conference Participation (Business Wire)
10:01AM	Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-18-24 09:35AM	Down -21.69% in 4 Weeks, Here's Why Tandem Diabetes Care (TNDM) Looks Ripe for a Turnaround (Zacks)
Oct-09-24 03:50PM	Tandem Diabetes Care Inc (TNDM) Q2 2024 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com)
Oct-02-24 04:05PM	Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024 (Business Wire)
02:11PM	Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says (Benzinga)
07:43AM	Loading…
07:43AM	This pharma stock offers an attractive risk-reward says RBC (Investing.com)
Oct-01-24 06:34PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research)
05:39PM	Why Tandem Diabetes Care Stock Took It on the Chin Tuesday (Motley Fool)
Sep-20-24 06:33AM	Tandem secures approval for t:slim X2 insulin pump to use with Lyumjev (Medical Device Network)
Sep-19-24 06:49PM	Why Tandem Diabetes Care Stock Thrashed the Market Today (Motley Fool)
09:00AM	Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union (Business Wire)
Sep-12-24 06:30PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research)
01:12AM	Capital World Investors Reduces Stake in Tandem Diabetes Care Inc (GuruFocus.com)
Sep-04-24 06:30PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research)
Aug-26-24 04:05PM	Tandem Diabetes Care Announces Upcoming Conference Participation (Business Wire)
Aug-19-24 06:30PM	Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall (Business Wire) -8.27%
Aug-16-24 09:04PM	Tandem Diabetes Care, Inc. (TNDM): Should You Add This Diabetes Stock To Your Portfolio Now? (Insider Monkey)
Aug-15-24 06:24PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research) +5.06%
07:19AM	Tandem warns iPhone app still draining insulin pump batteries (MedTech Dive)
Aug-12-24 04:30PM	Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices (Business Wire) +5.66%
09:47AM	Loading…
Aug-05-24 09:47AM	Tandem Diabetes (TNDM) Q2 Earnings Beat, '24 View Raised (Zacks)
Aug-02-24 11:13AM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research) +18.35%
07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Aug-01-24 07:30PM	Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
06:10PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance (Business Wire)
Jul-30-24 04:05PM	Tandem Diabetes Care Announces Upcoming Conference Presentation (Business Wire)
Jul-29-24 09:00AM	Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada (Business Wire) -7.07%
Jul-26-24 09:37AM	Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge? (The Wall Street Journal)
Jul-25-24 06:19PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research)
Jul-11-24 04:05PM	Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024 (Business Wire)
Jul-10-24 06:29PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research)
Jul-01-24 04:24PM	Tandem Diabetes (TNDM) Posts Positive Data for Tandem Mobi (Zacks)
Jun-24-24 08:38PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research) -6.68%
07:13AM	Tandem showcases data from user survey of Tandem Mobi (Medical Device Network)
Jun-22-24 11:00AM	Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions (Business Wire)
Jun-21-24 02:42AM	Tandem names Jean-Claude Kyrillos as chief operating officer (MedTech Dive)
Jun-20-24 09:00AM	Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer (Business Wire)
Jun-19-24 06:02AM	The 3 Best Diabetes Stocks to Buy in June 2024 (InvestorPlace)
Jun-18-24 09:00AM	Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Associations 84th Scientific Sessions (Business Wire)
Jun-05-24 08:13AM	Here's Why You Should Hold on to Tandem Diabetes (TNDM) Now (Zacks)
May-30-24 10:28AM	Tandem Diabetes (TNDM) Connects Mobi Pump With Dexcom G7 Sensor (Zacks)
May-29-24 08:30AM	Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM (Business Wire)
May-23-24 04:05PM	Tandem Diabetes Care Announces Upcoming Conference Presentation (Business Wire)
May-17-24 09:42AM	Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It? (Zacks)
May-03-24 04:34PM	Why Tandem Diabetes Stock Just Jumped 22% (Motley Fool) +22.32%
03:38PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research)
12:03PM	Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:01AM	UBS Adjusts Price Target on Tandem Diabetes Care to $40 From $28, Maintains Neutral Rating (MT Newswires)
09:33AM	Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View (Zacks)
07:46AM	Q1 2024 Tandem Diabetes Care Inc Earnings Call (Thomson Reuters StreetEvents)
04:03AM	Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
May-02-24 08:56PM	TNDM Stock Earnings: Tandem Diabetes Care Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:30PM	Tandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:50PM	Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings: Outperforms Revenue Estimates and Updates ... (GuruFocus.com)
05:30PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance (Business Wire)
Apr-29-24 04:05PM	Tandem Diabetes Care Announces Upcoming Conference Presentations (Business Wire) +5.14%
Apr-25-24 10:02AM	Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline (Zacks)
Apr-09-24 04:05PM	Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024 (Business Wire)
Apr-07-24 12:07PM	1 Beaten-Down Stock That Could Make You Richer (Motley Fool)
Apr-05-24 05:01AM	Should You Invest in Tandem Diabetes Care (TNDM)? (Insider Monkey)
Apr-01-24 10:41AM	Tandem Diabetes (TNDM) Gains From Innovation Amid Macro Issues (Zacks)
Mar-26-24 03:05PM	Why Tandem Diabetes Care Stock Was Zooming Higher Today (Motley Fool) +11.93%
Mar-22-24 12:24PM	Tandem Diabetes (TNDM) Gains From Innovation Amid Competition (Zacks) -5.02%
11:30AM	Why Is Tandem Diabetes Care (TNDM) Up 27.4% Since Last Earnings Report? (Zacks)
Mar-20-24 04:30PM	Shhh! 7 Small-Cap Stocks That Can Double by 2025 (InvestorPlace) +5.39%
05:27AM	Here are the Reasons to Invest in Tandem Diabetes Care (TNDM) (Insider Monkey)
Mar-19-24 08:14AM	Here's Why You Should Retain Tandem Diabetes (TNDM) Now (Zacks)
Mar-18-24 09:05AM	Parexel Announces CEO Succession Plan (GlobeNewswire) +8.74%
Mar-11-24 02:03PM	Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher (Investor's Business Daily)
Mar-08-24 06:19AM	Tandem Diabetes Care, Inc. (TNDM) Surges 9.6%: Is This an Indication of Further Gains? (Zacks)
Mar-06-24 12:46AM	Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029 (Business Wire)
Mar-04-24 04:05PM	Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes (Business Wire) +12.91% -12.96%
Mar-02-24 08:54AM	Senseonics Holdings, Inc. (AMEX:SENS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-23-24 06:25PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research) +16.52%
Feb-22-24 06:55PM	Why Tandem Diabetes Care Stock Popped Today (Motley Fool) +10.86%
12:17PM	Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research)
09:41AM	Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:31AM	Tandem Diabetes (TNDM) Posts Wider Q4 Loss, Gross Margin Down (Zacks)
06:16AM	Q4 2023 Tandem Diabetes Care Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 06:00PM	Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:25PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:40PM	Tandem Diabetes Care Inc (TNDM) Reports Mixed 2023 Results and Sets 2024 Guidance (GuruFocus.com)
04:05PM	Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance (Business Wire)
Feb-15-24 09:22AM	Tandem (TNDM) Broadens Insulin Pumps Line in the U.S. With Mobi (Zacks)
Feb-14-24 10:00AM	Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings Expected to Decline (Zacks)
Feb-13-24 08:30AM	Tandem Diabetes Care Launches Tandem Mobi, the Worlds Smallest, Durable Automated Insulin Delivery System (Business Wire)
Feb-08-24 04:05PM	Tandem Diabetes Care Announces Upcoming Conference Presentations (Business Wire)
Feb-04-24 07:30AM	2 Beaten-Down Stocks That Are Worth Buying (Motley Fool)

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BLICKENSTAFF KIM D	Director	Nov 21 '24	Sale	31.38	30,000	941,400	165,190	Nov 22 04:08 PM
BLICKENSTAFF KIM D	Director	Nov 20 '24	Sale	30.00	10,000	300,000	195,190	Nov 22 04:08 PM
BLICKENSTAFF KIM D	Board of Directors, Chair Emer	Nov 21 '24	Proposed Sale	30.00	30,000	900,000		Nov 21 11:22 AM
BLICKENSTAFF KIM D	Board of Directors Chair Emeri	Nov 20 '24	Proposed Sale	120.00	10,000	1,200,000		Nov 20 04:52 PM
Novara Mark David	EVP & CHIEF COMMERCIAL OFFICER	Nov 15 '24	Buy	23.24	532	12,364	532	Nov 19 05:23 PM
Carpenter Rick	Chief Technology Officer	Nov 15 '24	Option Exercise	0.00	2,033	0	14,624	Nov 19 05:23 PM
Morrison Susan	EVP & Chief Admin. Officer	Nov 15 '24	Option Exercise	0.00	2,140	0	25,329	Nov 19 05:22 PM
Hansen Shannon Marie	EVP & Chief Legal Officer	Nov 15 '24	Option Exercise	0.00	1,967	0	11,455	Nov 19 05:22 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Nov 15 '24	Option Exercise	0.00	2,140	0	22,119	Nov 19 05:22 PM
Sheridan John F	PRESIDENT & CEO	Nov 15 '24	Option Exercise	0.00	8,499	0	56,729	Nov 19 05:22 PM
Gasser Elizabeth Anne	EVP, Chief Strategy Officer	Nov 15 '24	Option Exercise	0.00	2,140	0	2,877	Nov 19 05:22 PM
Carpenter Rick	Chief Technology Officer	Sep 16 '24	Option Exercise	0.00	406	0	12,949	Sep 18 05:06 PM
Hansen Shannon Marie	EVP & Chief Legal Officer	Aug 15 '24	Option Exercise	0.00	1,968	0	10,191	Aug 19 08:31 PM
Carpenter Rick	Chief Technology Officer	Aug 15 '24	Option Exercise	0.00	2,033	0	13,056	Aug 19 08:31 PM
Sheridan John F	PRESIDENT & CEO	Aug 15 '24	Option Exercise	0.00	8,501	0	52,540	Aug 19 08:31 PM
Gasser Elizabeth Anne	EVP, Chief Strategy Officer	Aug 15 '24	Option Exercise	0.00	2,140	0	1,911	Aug 19 08:31 PM
Morrison Susan	EVP & Chief Admin. Officer	Aug 15 '24	Option Exercise	0.00	2,140	0	23,802	Aug 19 08:31 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Aug 15 '24	Option Exercise	0.00	2,140	0	20,744	Aug 19 08:31 PM
Carpenter Rick	Chief Technology Officer	Jun 17 '24	Option Exercise	0.00	406	0	11,381	Jun 20 04:42 PM
Cha Myoungil	Director	Jun 17 '24	Option Exercise	45.33	1,749	79,282	7,563	Jun 20 04:42 PM
Malagueira Joao Paulo Falcao	Director	Jun 17 '24	Option Exercise	45.33	1,749	79,282	7,563	Jun 20 04:41 PM
Allen Dick	Director	May 30 '24	Sale	51.68	5,000	258,400	0	Jun 03 04:22 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	May 28 '24	Option Exercise	0.00	406	0	18,978	May 28 06:45 PM
Leal James	Chief Manufacturing Officer	May 28 '24	Option Exercise	0.00	310	0	17,005	May 28 06:44 PM
Sheridan John F	PRESIDENT & CEO	May 28 '24	Option Exercise	0.00	820	0	45,991	May 28 06:44 PM
Gasser Elizabeth Anne	EVP, Chief Strategy Officer	May 28 '24	Option Exercise	0.00	373	0	11,883	May 28 06:44 PM
Morrison Susan	EVP & Chief Admin. Officer	May 28 '24	Option Exercise	0.00	406	0	21,962	May 28 06:44 PM
Cha Myoungil	Director	May 24 '24	Option Exercise	51.73	4,065	210,282	5,814	May 24 07:23 PM
Howell Peyton R	Director	May 24 '24	Option Exercise	51.73	4,434	229,371	16,690	May 24 07:22 PM
TWOMEY CHRISTOPHER J	Director	May 24 '24	Option Exercise	51.73	4,434	229,371	11,288	May 24 07:22 PM
McGroddy-Goetz Kathleen	Director	May 24 '24	Option Exercise	51.73	4,434	229,371	13,466	May 24 07:22 PM
Malagueira Joao Paulo Falcao	Director	May 24 '24	Option Exercise	51.73	4,065	210,282	5,814	May 24 07:22 PM
Sodhi Rajwant	Director	May 24 '24	Option Exercise	51.73	4,434	229,371	11,134	May 24 07:21 PM
ROBERTSON REBECCA B	Director	May 24 '24	Option Exercise	51.73	4,434	229,371	9,396	May 24 07:21 PM
Allen Dick	Director	May 24 '24	Option Exercise	51.73	4,434	229,371	24,396	May 24 07:21 PM
BLICKENSTAFF KIM D	Director	May 24 '24	Option Exercise	51.73	4,434	229,371	17,848	May 24 07:21 PM
Gasser Elizabeth Anne	EVP, Chief Strategy Officer	May 15 '24	Option Exercise	0.00	6,648	0	13,656	May 17 05:47 PM
Morrison Susan	EVP & Chief Admin. Officer	May 15 '24	Option Exercise	0.00	6,648	0	23,276	May 17 05:47 PM
Carpenter Rick	Chief Technology Officer	May 15 '24	Option Exercise	0.00	6,343	0	13,026	May 17 05:47 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	May 15 '24	Option Exercise	0.00	6,648	0	20,718	May 17 05:46 PM
Hansen Shannon Marie	Chief Legal Officer	May 15 '24	Option Exercise	0.00	6,279	0	10,464	May 17 05:46 PM
Leal James	Chief Manufacturing Officer	May 15 '24	Option Exercise	0.00	9,021	0	19,072	May 17 05:46 PM
Sheridan John F	PRESIDENT & CEO	May 15 '24	Option Exercise	0.00	24,915	0	54,245	May 17 05:45 PM
Carpenter Rick	Chief Technology Officer	Mar 15 '24	Option Exercise	0.00	405	0	6,245	Mar 19 04:23 PM
Morrison Susan	EVP & Chief Admin. Officer	Feb 27 '24	Option Exercise	0.00	407	0	15,564	Feb 29 05:13 PM
Sheridan John F	PRESIDENT & CEO	Feb 27 '24	Option Exercise	0.00	819	0	30,181	Feb 29 05:13 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Feb 27 '24	Option Exercise	0.00	407	0	13,082	Feb 29 05:13 PM
Gasser Elizabeth Anne	EVP, Chief Strategy Officer	Feb 27 '24	Option Exercise	0.00	372	0	6,553	Feb 29 05:12 PM
Leal James	Chief Manufacturing Officer	Feb 27 '24	Option Exercise	0.00	309	0	10,941	Feb 29 05:12 PM
Morrison Susan	EVP & Chief Admin. Officer	Feb 15 '24	Option Exercise	0.00	638	0	15,319	Feb 20 07:28 PM
Carpenter Rick	Chief Technology Officer	Feb 15 '24	Option Exercise	0.00	596	0	6,085	Feb 20 07:27 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Feb 15 '24	Option Exercise	0.00	638	0	12,870	Feb 20 07:27 PM
Leal James	Chief Manufacturing Officer	Feb 15 '24	Option Exercise	0.00	973	0	11,008	Feb 20 07:27 PM
Gasser Elizabeth Anne	EVP, Chief Strategy Officer	Feb 15 '24	Option Exercise	0.00	638	0	6,376	Feb 20 07:26 PM
Sheridan John F	PRESIDENT & CEO	Feb 15 '24	Option Exercise	0.00	3,029	0	30,279	Feb 20 07:26 PM
Hansen Shannon Marie	Chief Legal Officer	Feb 15 '24	Option Exercise	0.00	531	0	3,794	Feb 20 07:26 PM
Sodhi Rajwant	Director	Jan 04 '24	Option Exercise	27.66	1,070	29,596	6,700	Jan 08 04:06 PM
Carpenter Rick	Chief Technology Officer	Dec 15 '23	Option Exercise	0.00	406	0	5,630	Dec 19 04:14 PM
Allen Dick	Director	Nov 27 '23	Buy	18.96	5,000	94,778	19,962	Nov 29 04:10 PM
BERGER DAVID B	EVP & Chief Operating Officer	Nov 27 '23	Option Exercise	0.00	406	0	6,479	Nov 29 04:10 PM
Sheridan John F	PRESIDENT & CEO	Nov 27 '23	Option Exercise	0.00	820	0	27,859	Nov 29 04:09 PM
Leal James	Chief Manufacturing Officer	Nov 27 '23	Option Exercise	0.00	310	0	10,242	Nov 29 04:09 PM
Gasser Elizabeth Anne	EVP, Chief Strategy Officer	Nov 27 '23	Option Exercise	0.00	373	0	5,934	Nov 29 04:09 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Nov 27 '23	Option Exercise	0.00	406	0	12,757	Nov 29 04:09 PM
Morrison Susan	EVP & Chief Admin. Officer	Nov 27 '23	Option Exercise	0.00	406	0	14,853	Nov 29 04:08 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Nov 27 '23	Option Exercise	0.00	406	0	12,440	Nov 29 04:08 PM

Open in Screener

NUVB

Nuvation Bio Inc

Nov 26 • 04:00PM ET

2.89

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NYSE

Peers: GILD AMGN REGN VRTX BIIB MRNA BMY PFE LLY SNY

| Held by: IWM VTI VXF IWN IBB SCHA VTWO DFAC IWC IHE

Index	RUT	P/E	-	EPS (ttm)	-2.17	Insider Own	32.40%	Shs Outstand	337.57M	Perf Week	11.58%
Market Cap	975.57M	Forward P/E	-	EPS next Y	-0.61	Insider Trans	0.88%	Shs Float	228.20M	Perf Month	22.98%
Income	-532.28M	PEG	-	EPS next Q	-0.14	Inst Own	43.46%	Short Float	4.96%	Perf Quarter	-11.62%
Sales	2.16M	P/S	451.65	EPS this Y	-517.71%	Inst Trans	31.54%	Short Ratio	6.00	Perf Half Y	-1.03%
Book/sh	1.50	P/B	1.93	EPS next Y	71.69%	ROA	-88.53%	Short Interest	11.32M	Perf Year	127.56%
Cash/sh	1.63	P/C	1.78	EPS next 5Y	-	ROE	-95.54%	52W Range	1.22 - 4.16	Perf YTD	91.39%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-105.67%	52W High	-30.53%	Beta	1.45
Dividend TTM	-	Quick Ratio	9.57	Sales past 5Y	0.00%	Gross Margin	-56.38%	52W Low	136.89%	ATR (14)	0.18
Dividend Ex-Date	-	Current Ratio	9.57	EPS Y/Y TTM	-473.10%	Oper. Margin	-6218.59%	RSI (14)	60.94	Volatility	6.23% 6.70%
Employees	51	Debt/Eq	0.02	Sales Y/Y TTM	-	Profit Margin	-24619.84%	Recom	1.00	Target Price	6.50
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	-67.71%	Payout	-	Rel Volume	1.20	Prev Close	2.89
Sales Surprise	-	EPS Surprise	-19.05%	Sales Q/Q	-	Earnings	Nov 06 AMC	Avg Volume	1.89M	Price	2.89
SMA20	9.26%	SMA50	15.53%	SMA200	3.28%	Trades		Volume	2,261,341	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-27-24	Upgrade	Jefferies	Hold → Buy	$1.40 → $10
Mar-26-24	Upgrade	BTIG Research	Neutral → Buy	$5
Jan-06-23	Downgrade	Jefferies	Buy → Hold	$5 → $2
Aug-02-22	Downgrade	BTIG Research	Buy → Neutral
Aug-02-22	Downgrade	BMO Capital Markets	Outperform → Market Perform	$8 → $2.50
May-04-22	Initiated	H.C. Wainwright	Buy	$14
Oct-15-21	Resumed	BTIG Research	Buy	$16
Apr-06-21	Initiated	RBC Capital Mkts	Outperform	$15
Mar-08-21	Initiated	Wedbush	Outperform	$20
Mar-08-21	Initiated	Jefferies	Buy	$20
Mar-08-21	Initiated	Cowen	Outperform
Mar-08-21	Initiated	BTIG Research	Buy	$16
Mar-08-21	Initiated	BMO Capital Markets	Outperform	$16

Show Previous Ratings

Today 08:00AM	Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference (Business Wire)
Nov-12-24 04:05PM	Nuvation Bio to Present at the Jefferies London Healthcare Conference (Business Wire)
Nov-06-24 04:05PM	Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update (Business Wire) +9.48%
01:11AM	Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline (Insider Monkey)
Oct-16-24 09:06AM	Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds? (Insider Monkey) +10.30%
11:51AM	Loading…
Oct-14-24 11:51AM	Is Nuvation Bio Inc. (NUVB) Hedge Funds Favorite Penny Stock? (Insider Monkey)
Oct-09-24 08:02AM	Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35 (Insider Monkey)
Oct-07-24 04:05PM	Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer (Business Wire) -9.96%
Oct-02-24 02:02AM	Navigating Legal Uncertainty: Nuvation Bio Inc.s Chinese Operations and the Shifting Landscape of Chinas Civil Law System (TipRanks)
Sep-14-24 03:05AM	Positive Pooled Data from Nuvation Bio's TRUST-I and TRUST-II Studies Highlight Taletrectinib's Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024 (Business Wire)
Sep-09-24 08:00AM	Nuvation Bio to Present at the Cantor Global Healthcare Conference (Business Wire) +6.45%
Aug-06-24 06:32AM	Nuvation Bio pauses oncology drug after Phase I efficacy and safety analysis (Clinical Trials Arena) -6.29%
Aug-05-24 02:27PM	Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data (Benzinga) -5.36%
08:00AM	Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update (Business Wire)
Jul-23-24 04:05PM	Nuvation Bio Announces Updates and Upcoming Presentations for its ROS1 Inhibitor, Taletrectinib (Business Wire) +10.06%
01:13AM	Loading…
Jun-02-24 01:13AM	Innovent Announces TaletrectinibROS1 InhibitorUpdated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting (PR Newswire)
Jun-01-24 08:10AM	Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting (Business Wire)
May-29-24 04:05PM	Nuvation Bio to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-14-24 10:54PM	NUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024 (InvestorPlace)
05:08PM	Nuvation Bio Q1 Loss Narrows; Shares Fall After Hours (MT Newswires)
04:05PM	Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update (Business Wire)
Apr-24-24 10:01AM	Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (Business Wire)
Apr-10-24 04:01PM	Nuvation Bio Completes Acquisition of AnHeart Therapeutics (Business Wire) -5.57%
Mar-28-24 08:00AM	Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer (Business Wire) -8.31%
Mar-25-24 07:00AM	Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction (Business Wire)
Mar-14-24 04:05PM	Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors (Business Wire) -9.13%
08:45AM	Biotech's Role in Addressing the Pancreatic Cancer Emergency (PR Newswire)
Mar-08-24 12:00PM	Nuvation Bio Inc. (NUVB) Is Up 25.28% in One Week: What You Should Know (Zacks)
Feb-29-24 04:01PM	Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (Business Wire) -5.08% +19.25%
Feb-27-24 03:30AM	12 Best Medical Stocks to Buy Under $10 (Insider Monkey)
04:10PM	Loading…
Jan-08-24 04:10PM	Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors (Business Wire)
04:05PM	Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors (Business Wire)
Nov-13-23 04:05PM	Nuvation Bio Announces Departure of Chief Financial Officer (Business Wire) +5.47%
Nov-02-23 06:04PM	Nuvation Bio Inc (NUVB) Reports Q3 2023 Financial Results (GuruFocus.com) +10.34% +5.47%
04:10PM	Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Aug-03-23 04:10PM	Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Jul-13-23 09:45AM	15 Best Penny Stocks To Buy Now (Insider Monkey)
Jun-01-23 04:05PM	Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board (Business Wire)
May-16-23 06:23AM	Nuvation Bio Insider Ups Holding During Year \ (Simply Wall St.)
May-04-23 04:05PM	Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Mar-21-23 05:10PM	12 Best Biotech Stocks To Buy Under $20 (Insider Monkey) -5.17%
Mar-18-23 06:48PM	The 7 Worst Stocks to Buy Now (InvestorPlace)
Mar-15-23 04:05PM	Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire)
Feb-17-23 05:05AM	With 48% stake, Nuvation Bio Inc. (NYSE:NUVB) seems to have captured institutional investors' interest (Simply Wall St.)
Jan-17-23 08:19AM	Companies Like Nuvation Bio (NYSE:NUVB) Are In A Position To Invest In Growth (Simply Wall St.)
Dec-19-22 04:05PM	Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868 (Business Wire) -5.08% +15.48%
Dec-07-22 05:03AM	Trade Alert: The Independent Director Of Nuvation Bio Inc. (NYSE:NUVB), Kathryn Falberg, Has Just Spent US$484k Buying A Few More Shares (Simply Wall St.)
Nov-03-22 04:05PM	Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-11-22 10:01AM	ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox (GlobeNewswire)
Aug-10-22 08:45AM	Nuvation Bio (NYSE:NUVB) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Aug-04-22 04:05PM	Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire) +5.06%
Aug-01-22 04:00PM	David Hung's Nuvation to cut 30 jobs, end cancer drug program (American City Business Journals) -9.78% -8.03%
09:52AM	After FDA Hold, Nuvation Bio Stops NUV-422 Cancer Development Program (Benzinga)
08:00AM	Nuvation Bio Announces Discontinuation of NUV-422 Clinical Development Program (Business Wire)
Jul-27-22 12:00PM	Nuvation Bio Inc. (NUVB) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Jul-18-22 07:00AM	Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief Regulatory Officer (Business Wire)
Jun-27-22 08:52AM	FDA Institutes Partial Hold On Nuvation Bio's Early-Stage Solid Tumor Trial - Read Why (Benzinga) -13.13%
07:00AM	Nuvation Bio Announces FDA Partial Clinical Hold for Phase 1 Study of NUV-422 in Solid Tumors (Business Wire)
May-23-22 11:36AM	Legendary Value Investor Seth Klarman is Buying These 10 Stocks (Insider Monkey) -8.70%
May-09-22 04:05PM	Nuvation Bio Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire) -6.21%
Feb-28-22 04:05PM	Nuvation Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (Business Wire) -5.07%
Jan-21-22 10:21AM	Nuvation (NUVB) Gets FDA Clearance for Oncology Candidate (Zacks)
Jan-20-22 08:43AM	FDA clears Nuvation Bio's IND Application For NUV-868 In Advanced Solid Tumors (Benzinga)
07:00AM	Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-868 for the Treatment of Advanced Solid Tumors (PR Newswire)
Jan-14-22 12:31PM	Where Do Hedge Funds Stand On Nuvation Bio Inc. (NUVB)? (Insider Monkey)
Jan-10-22 07:00AM	Nuvation Bio Provides Corporate Update and Highlights Key 2022 Milestones (PR Newswire)
Dec-17-21 08:00AM	Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies (PR Newswire) -8.74%
Dec-15-21 07:00AM	Nuvation Bio Receives FDA Fast Track Designation for NUV-422 for the Treatment of High-Grade Gliomas, Including Glioblastoma Multiforme (PR Newswire)
Dec-13-21 10:33AM	Billionaire Israel Englander Snaps Up These 3 Strong Buy Stocks (TipRanks) +8.98%
07:00AM	Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Prostate Cancer (PR Newswire)
Dec-08-21 07:00AM	Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Advanced Breast Cancer (PR Newswire)
Nov-19-21 08:24AM	Is Nuvation Bio Inc. (NYSE:NUVB) Popular Amongst Insiders? (Simply Wall St.)
Nov-10-21 04:05PM	Nuvation Bio Reports Third Quarter 2021 Financial Results and Provides Business Update (PR Newswire)
Oct-25-21 09:12AM	Is Nuvation Bio Inc. (NUVB) A Good Stock To Buy? (Insider Monkey) +6.52%
Sep-20-21 04:14PM	15 Best Stocks to Invest in Today According to David Abrams (Insider Monkey)
Aug-12-21 04:05PM	Nuvation Bio Reports Second Quarter 2021 Financial Results and Provides Business Update (PR Newswire) +5.35%
Jul-06-21 10:20AM	Should I Buy Nuvation Bio Inc. (NUVB)? (Insider Monkey)
Jun-01-21 07:00AM	Nuvation Bio Appoints David C. Hanley, Ph.D., as Chief Technical Operations Officer (PR Newswire)
May-26-21 07:00AM	Nuvation Bio to Participate in the Jefferies Virtual Healthcare Conference (PR Newswire)
May-21-21 04:34PM	David Abrams Buys 3 Stocks in 1st Quarter (GuruFocus.com)
May-17-21 05:00PM	Nuvation Bio Reports First Quarter 2021 Financial Results and Provides Business Update (PR Newswire) +8.08%
May-11-21 05:51AM	How Much Of Nuvation Bio Inc. (NYSE:NUVB) Do Insiders Own? (Simply Wall St.)
Apr-17-21 09:36PM	Top Insider Buys Highlight for the Week of April 16 (GuruFocus.com)
Mar-11-21 05:15PM	Nuvation Bio Reports Full Year 2020 Financial Results and Provides Business Update (PR Newswire) +7.28%
07:00AM	Nuvation Bio Granted Orphan Drug Designation for NUV-422 for the Treatment of Patients with Malignant Gliomas (PR Newswire)

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wang Junyuan Jerry	CEO, ANHEART THERAPEUTICS LTD.	Nov 11 '24	Sale	2.89	56,361	162,883	3,866,228	Nov 13 04:28 PM
Mashal Robert	Director	Oct 08 '24	Buy	2.20	100,000	220,000	100,000	Oct 10 04:33 PM
Cui Xiangmin	Director	Jun 25 '24	Buy	2.97	277,895	825,348	2,453,131	Jun 26 04:31 PM
Cui Xiangmin	Director	Jun 24 '24	Buy	2.98	336,874	1,003,885	2,175,236	Jun 25 05:45 PM
Cui Xiangmin	Director	Jun 20 '24	Buy	2.99	87,715	262,268	1,762,951	Jun 25 05:45 PM
Cui Xiangmin	Director	Jun 21 '24	Buy	3.00	75,411	226,233	1,838,362	Jun 25 05:45 PM
BLICKENSTAFF KIM D	Director	Jun 11 '24	Buy	2.90	172,189	500,089	172,189	Jun 13 04:33 PM
WELCH DANIEL G	Director	May 24 '24	Option Exercise	1.68	659,947	1,111,633	659,947	May 29 04:38 PM

TNDM

Tandem Diabetes Care Inc

NUVB

Nuvation Bio Inc

Upgrade your FINVIZ experience